Merck stock eased after a double-digit jump tied to its personalized cancer vaccine news, while Q2 2

Current Merck & Co Inc (Derivatives) (MRK) token data: Price to United States Dollar (USD) - $ 150.10, Trading Volume 673.14K, Market Cap N/A.

Current Merck & Co Inc (Derivatives) (MRK) token data: Price to Russian Ruble (RUB) - ₽ 13,040, Trading Volume 58.48M, Market Cap N/A.

Current Merck & Co Inc (Derivatives) (MRK) token data: Price to South Korean Won (KRW) - ₩ 207,728, Trading Volume 114.02M, Market Cap N/A.

Comprehensive analysis of Merck & Co Inc (Derivatives) price dynamics, quarterly returns, and annual trends in dollars. Our detailed research unveils dynamic interconnections between Merck & Co Inc (Derivatives) and the US dollar, providing valuable insights based on current data.

Historical data tab for Merck & Co Inc (Derivatives) in USD for download and research

Check the Merck & Co Inc (Derivatives) price history from each day since it was listed on CoinMarketCap. Fiat currency selection. MRK closing prices. Daily, weekly and monthly price data. Free download available.

See the latest MRK/AUD price and convert Merck & Co Inc (Derivatives) to Australian Dollar with our instant converter. 1 MRK is currently worth 209.95 AUD.

The live Merck & Co Inc (Derivatives) price today is $149.46 USD with a 24-hour trading volume of $0 USD. We update our MRK to USD price in real-time.

Merck & Co. Inc. compró una nueva participación en Moderna, Inc. (NASDAQ:MRNA - Free Report) en el segundo trimestre, según la compañía en su presentación más reciente del Formulario 13F ante la SEC. El fondo compró 2.308.190 acciones de la empresa.

Merck & Co. Inc. adquirió una nueva posición en acciones de Kymera Therapeutics, Inc. (NASDAQ:KYMR - Free Report) en el segundo trimestre, según su presentación 13F más reciente ante la Comisión de Bolsa y Valores. La firma adquirió 772.165 acciones de la empresa.

On August 19, 2026, Moderna, Inc. (NASDAQ:MRNA) and Merck & Co., Inc. (NYSE:MRK) said that their personalized mRNA cancer vaccine, combined with Merck’s Keytruda, met its main goals in a first-ever Phase 3 trial for melanoma. The news sent Moderna shares up as much as 177%, adding $44 billion to its market value, while Merck […]

B. Metzler seel. Sohn & Co. AG trimmed its position in shares of Merck & Co., Inc. (NYSE:MRK - Free Report) by 2.6% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 443,208 shares of the company

Current Merck & Co Inc (Derivatives) (MRK) token data: Price to British Pound Sterling (GBP) - £ 110.53, Trading Volume 75.68K, Market Cap N/A.

Merck stock is trading close to its 52 week high as investors weigh a strong second quarter revenue